Navigation Links
ECLIPSE Data on Effects of Otsuka's Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients' Hemodynamics and Urine Output Featured in Heart Failure Society of America's Late Breaking Trials
Date:9/19/2007

out ECLIPSE

ECLIPSE is an international, multicenter, randomized, placebo-controlled single-dose trial conducted at 48 trials sites in United States, Romania and Bulgaria between 2005 and 2006. ECLIPSE investigators enrolled patients with heart failure (New York Heart Association Class III or IV) for at least three months duration due to left ventricular systolic dysfunction and who had a left ventricular ejection fraction (LVEF) of 40 percent or less.

Investigators assessed patients' inclusion criteria for up to two weeks prior to randomization. Suitable candidates underwent insertion of a balloon- floatation pulmonary artery catheter to assess final eligibility criteria. Final doses of cardiac concomitant medications were administered at least two hours prior to catheter insertion. Following catheter insertion, patients entered into a two- to 20-hour stabilization period. Researchers completed hemodynamic assessments periodically during this period to determine final subject eligibility. Potential participants then entered a two-hour baseline period. If a participant met all criteria during the baseline period, he or she was randomly assigned to one of four groups and received a single once- daily oral tablet of placebo or of 15, 30 or 60 milligrams (mg) tolvaptan. Investigators followed participants for up to 24 hours for assessments.

"The ECLIPSE data add` to our existing knowledge about tolvaptan and its prospective uses," said Taro Iwamoto, CEO, COO and President of Otsuka Pharmaceutical Development & Commercialization, Inc. "Tolvaptan, as one of our most advanced candidate therapies, represents the successful application of Otsuka's expertise in the research and development of new medicines."

About Heart Failure

More than 14 million people in Europe(1) and five million U.S. residents(2) have heart failure (HF), a serious chronic condition in which the heart cannot effectively pump blood. The direct and indirect U.S. health care e
'/>"/>

SOURCE Otsuka America Pharmaceutical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
2. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
3. Promising Data on Cognitive Effects of Safinamide in Early Parkinsons Disease
4. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
5. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
6. New Data Suggests Less Abuse-Related Effects For OROS Methylphenidate
7. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacells Onconase
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Calif. , June 19, 2013 Pharmacyclics, ... announced that The New England Journal of Medicine ... 2 study evaluating the investigational oral Bruton,s tyrosine kinase ... lymphoma (MCL) online. These data suggested ibrutinib may be ... Results of a separate study examining ...
(Date:6/19/2013)...  Haemonetics Corporation (NYSE: HAE ) ... of its previously announced manufacturing transformation.  ... , Haemonetics has selected Sanmina Corporation (NASDAQ: ... medical devices currently manufactured in Braintree ... of integrated manufacturing solutions, components, products and repair, ...
(Date:6/19/2013)... YORK , June 19, 2013 /PRNewswire-iReach/ -- ... pioneer of modern hair transplant procedures and founder ... was included in the ,Best Doctors, issue of ... (Photo:  http://photos.prnewswire.com/prnh/20130619/CG34629 ) ... Best Doctors issue, and his reputation as world-renowned ...
Breaking Medicine Technology:Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3
(Date:6/19/2013)... As warmer weather arrives and vacations begin, Asheville’s ... summertime packages. , “Whether guests are traveling to Asheville ... staycation, we think that these available packages will offer ... so beautiful in the summertime and there is a ... can choose from, based on their interests, offers something ...
(Date:6/19/2013)... 2013 According to Fastcare ... sun exposure is perhaps the biggest and certainly ... that is just one of many potential factors ... cancer. Other risk factors include:, , ... ,     Heredity may play a role , ...
(Date:6/19/2013)... The benefits, NASS said, ... the overall experience for the majority of those who ... Mr Mouw, whose Virgina-based company enjoys an international clientele, ... saying that the type of sauna is also important. ... counterfeit imitations which frankly, can be extremely dangerous particularly ...
(Date:6/19/2013)... Hollywood, CA (PRWEB) June 19, 2013 ... conditions with little to no access to the medical ... organizations are providing access to health care and the ... of these third-world nations. , Outlook with ... organizations to reveal the conditions in which these people ...
(Date:6/19/2013)... 19, 2013 Daily Gossip issued a press ... method will be published on their website at the ... article to inform readers about the information they will find ... reporters working at Daily Gossip, the article is a review ... , Hiller has understood during the vast research he has ...
Breaking Medicine News(10 mins):Health News:Fun Depot Partners with Brookstone Lodge on Summer Packages 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2
... , DENVER, CO , Jan. 28 ... MIT is pleased to announce that it has started ... Jacques Gauthier and Mr. Michel Carrier as members ... has served on the board of directors of Axcan Pharma ...
... , Emergency Relief Fund Established for Haitian ... 28 The Assisted Living Federation of America ... Haitian employees of senior living companies. , "The employees of our ... seniors.  Now, in their hour of need, we offer support to ...
... CAMBRIDGE, Mass. , Jan. 28 DNA ... health through innovation, today announced it has been awarded ... from the National Aeronautics and Space Administration (NASA).  The ... facilitate whole health analysis in a single drop of ...
... part in a study thought that their obese four or five ... fathers, according to the February issue of Acta Paediatrica . ... of mothers and 77 per cent of fathers thought that their ... children took part in the study, carried out by researchers from ...
... innovative cardiac scanner will dramatically improve the process of ... developed at the University of Leeds, with funding from ... a key role. Due to its unprecedented ... to detect a number of conditions, including heart problems ...
... , ... Attempt, George Hood Utilizes Blogging, Facebook, Twitter, and LinkedIn to Raise Awareness, Funds ... Aurora, IL (PRWEB) January 28, ... Ultra endurance athlete is currently training to break the Guinness world record in stationary (spin) ...
Cached Medicine News:Health News:MIT is pleased to announce the nomination of Mr. Jacques Gauthier and Mr. Michel Carrier to its newly formed Advisory Board 2Health News:ALFA Extends Helping Hand to Haiti 2Health News:NASA selects DNA Medicine Institute's Nanoscale Diagnostics Technology for Phase II SBIR 2Health News:Most parents don't realize their 4 or 5 year-olds are overweight or obese 2Health News:Breakthrough heart scanner will allow earlier diagnosis 2Health News:Aurora Man's Guinness World Record Attempt Goes Social 2Health News:Aurora Man's Guinness World Record Attempt Goes Social 3Health News:Aurora Man's Guinness World Record Attempt Goes Social 4
Innotrac Aio! immunoanalyzers are specially designed to exploit the benefits of Innotrac Diagnostics' exclusive dry chemistry and non-enhancement time-resolved fluorometry....
... Synchron LXi 725 clinical system combines ... accurate immunoassay testing capabilities, innovative data ... a single platform. After tests are ... for optimal quality assurance. If reflex ...
... Access immunoassay system is ... benchtop analyzer that performs ... with panels that include ... infectious disease, blood virus, ...
...
Medicine Products: